Role of Dock8 in Mucosal Immunity
Dock8 在粘膜免疫中的作用
基本信息
- 批准号:10198713
- 负责人:
- 金额:$ 28.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:ActinsAffectApoptosisBacterial InfectionsBindingBiologyCDC42 geneCandidaCellsCitrobacter rodentiumClinicalCollaborationsConfocal MicroscopyCytoskeletonDataDevelopmentFamilyFunctional disorderGastrointestinal tract structureGenerationsGuanine Nucleotide Exchange FactorsHelper-Inducer T-LymphocyteHumanHypersensitivityIL7 geneImmuneImmune responseImmune systemImmunityImmunologic Deficiency SyndromesImpairmentIndividualInfectionKnock-in MouseKnockout MiceLymphoid CellMalignant NeoplasmsMass Spectrum AnalysisMediatingMolecularMonomeric GTP-Binding ProteinsMucosal ImmunityMusMycosesPatientsPlayProteinsProteomicsRecurrenceReporterReportingRoleScaffolding ProteinSet proteinSignal TransductionSkinStaphylococcus aureusSuggestionT-LymphocyteTechnologyTestingTh1 CellsTimeWaspsbasecell motilityconditional knockoutcytokinein vivointerleukin-22noveloral infectionpathogenrecurrent infectionresponserho GTP-Binding Proteinsselective expression
项目摘要
PROJECT SUMMARY
DOCK8 deficiency in humans leads to severe immunodeficiency. The clinical manifestations of DOCK8
immunodeficiency include recurrent infections, allergies, and malignancies. DOCK8 -deficient patients suffer
from recurrent bacterial infections such as Staphylococcus aureus and fungal infections of the mouth or skin
with Candida, which are suggestive of TH17 cell dysfunction. Although it has been suggested that DOCK8
might coordinate cytoskeletal arrangement, cellular detachment and regulate cell migration, the precise role of
DOCK proteins in the cell remains for the most part unknown. We have recently reported that DOCK8 is
essential for the protective immunity against C. rodentium. DOCK8-deficient mice succumb rapidly to C.
rodentium infection. DOCK8-deficient mice have very low numbers of IL-22-producing RORγt+ ILCs in
comparison to WT mice. DOCK8-deficient RORγt+ ILCs are defective in IL-7-mediated signaling, more prone to
apoptosis and produce less IL-22 than WT mice. We have also found that the generation of TH17 cells during
C. rodentium infection is selectively impaired, whereas the generation of TH1 cells is dramatically increased in
DOCK8-deficient mice in comparison to WT mice. DOCK8 is a very large protein that has been shown to
function as guanine nucleotide exchange factors (GEFs) that binds and activates small GTPases of the
Rho/Rac/Cdc42 family. In order to determine whether DOCK8 function in the generation of TH17 cells is
dependent on its GEF activity for CDC42, or its interaction with WASp, a protein that plays an important role in
the organization and function of the actin cytoskeleton, we infected mice in which CDC42 or WAS was
specifically eliminated in T cells. Whereas DOCK8-deficient mice were unable to mount a robust TH17 cell
response upon infection, CDC42 T cell-deficient or WAS T cell-deficient mice developed a TH17 cell response
as robust as WT mice. From this study, we concluded that at least for the development of TH17 cells, DOCK8
is likely acting as a scaffolding protein rather than a GEF for CDC42, or via its interaction with WASp. Thus, It
is possible that DOCK8 might act as a scaffolding protein that is important for the activation of unknown factors
necessary for the differentiation of TH17 cells. Here we hypothesize that DOCK8 regulates the function of
TH17 cells by interacting with a specific set of proteins selectively expressed in TH17 cells and not in TH1
cells. In order to identify proteins that interact with DOCK8 in vivo, we have generated a novel Knockin mouse
in which endogenous DOCK8 was fused to AVI tag, Flag and GFP reporter. The AVI tag technology will allow
us to perform proteomics and Mass spectrometry analysis in a relatively small number of primary T cells,
whereas the GFP will allow us to perform confocal microscopy and track DOCK8 subcellular localization in
both ILCs and TH17 cells. Overall, our proposed studies will help us understand why DOCK8 deficiency has
such a profound effect on the immune system.
项目摘要
人类的Dock8缺乏会导致严重的免疫缺陷。 DOCK8的临床表现
免疫缺陷包括复发性感染,过敏和恶性肿瘤。 Dock8-缺陷患者患者
从复发性细菌感染(例如金黄色葡萄球菌)和口腔或皮肤的真菌感染
与Th17细胞功能障碍有关的念珠菌。尽管有人建议Dock8
可能会协调细胞骨架布置,细胞脱离和调节细胞迁移,这是
细胞中的码头蛋白在大多数情况下仍然是未知的。我们最近报告说Dock8是
防御性免疫对啮齿动物的免疫力至关重要。 Dock8缺陷小鼠迅速屈服于C。
啮齿动物感染。 Dock8缺陷小鼠的IL-22产生RORγT+ ILC数量很少
与WT小鼠进行比较。 DOCK8缺陷RORγT+ ILC在IL-7介导的信号中有缺陷,更容易容易
凋亡比WT小鼠产生的IL-22少。我们还发现,在
C.啮齿动物感染有选择性地受损,而Th1细胞的产生显着增加
与WT小鼠相比,DOCK8缺陷小鼠。 Dock8是一种非常大的蛋白质,已显示为
充当鸟嘌呤核丁基交换因子(GEFS),该因子结合并激活了小的GTPases
RHO/RAC/CDC42家庭。为了确定dock8在产生Th17细胞中是否功能是
取决于其对CDC42的GEF活性,或与WASP相互作用的蛋白质,该蛋白在
肌动蛋白细胞骨架的组织和功能,我们感染了Cdc42或所在的小鼠
在T细胞中特别消除。而Dock8缺陷小鼠无法安装强大的Th17单元
感染后的反应,CDC42 T细胞缺陷型或T细胞缺陷小鼠会形成Th17细胞反应
像WT小鼠一样坚固。从这项研究中,我们得出结论,至少对于Th17细胞的发展,Dock8
可能充当脚手架蛋白,而不是用于CDC42的GEF,或者通过其与黄蜂的相互作用。那,它
Dock8可能充当脚手架蛋白,这对于激活未知因素很重要
分化Th17细胞所必需的。在这里,我们假设Dock8调节了
Th17细胞与在Th17细胞中选择的一组特定蛋白质相互作用,而不是在Th1中
细胞。为了鉴定与体内与Dock8相互作用的蛋白质,我们生成了一种新型的敲蛋白小鼠
其中内源性DOCK8与AVI标签,FLAG和GFP记者融合在一起。 AVI标签技术将允许
美国在相对较少的原代T细胞中执行蛋白质组学和质谱分析,
而GFP将使我们能够执行共聚焦显微镜并跟踪Dock8亚细胞定位
ILC和Th17细胞均被ILC。总体而言,我们拟议的研究将帮助我们了解为什么Dock8缺乏症
对免疫系统的深刻影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard Goff James其他文献
Richard Goff James的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard Goff James', 18)}}的其他基金
Critical role for Solute Carrier Proteins (SLCs) for mast cell function
溶质载体蛋白 (SLC) 对肥大细胞功能的关键作用
- 批准号:
10537469 - 财政年份:2022
- 资助金额:
$ 28.86万 - 项目类别:
Critical role for Solute Carrier Proteins (SLCs) for mast cell function
溶质载体蛋白 (SLC) 对肥大细胞功能的关键作用
- 批准号:
10652657 - 财政年份:2022
- 资助金额:
$ 28.86万 - 项目类别:
Mechanisms mediating resistance to ibrutinib in Non-Hodgkin's lymphoma
非霍奇金淋巴瘤伊布替尼耐药的介导机制
- 批准号:
9237831 - 财政年份:2017
- 资助金额:
$ 28.86万 - 项目类别:
In vivo role of BTK-mediated inhibition of Wnt/b-catenin signaling during hematop
BTK 介导的 Wnt/b-catenin 信号抑制在 hematop 过程中的体内作用
- 批准号:
8532963 - 财政年份:2010
- 资助金额:
$ 28.86万 - 项目类别:
In vivo role of BTK-mediated inhibition of Wnt/b-catenin signaling during hematop
BTK 介导的 Wnt/b-catenin 信号抑制在 hematop 过程中的体内作用
- 批准号:
8127876 - 财政年份:2010
- 资助金额:
$ 28.86万 - 项目类别:
In vivo role of BTK-mediated inhibition of Wnt/b-catenin signaling during hematop
BTK 介导的 Wnt/b-catenin 信号抑制在 hematop 过程中的体内作用
- 批准号:
8514128 - 财政年份:2010
- 资助金额:
$ 28.86万 - 项目类别:
In vivo role of BTK-mediated inhibition of Wnt/b-catenin signaling during hematop
BTK 介导的 Wnt/b-catenin 信号抑制在 hematop 过程中的体内作用
- 批准号:
7952613 - 财政年份:2010
- 资助金额:
$ 28.86万 - 项目类别:
相似国自然基金
VNN1通过内质网非折叠蛋白应激介导单核巨噬细胞凋亡影响创伤患者脓毒症发生的机制研究
- 批准号:82372549
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
草鱼贮藏过程肌细胞凋亡对鱼肉品质的影响机制研究
- 批准号:32372397
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
MLCK1介导细胞凋亡和自噬影响炎症性肠病进展
- 批准号:82370568
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
EHMT1通过CBX4/MLKL轴调控心肌细胞坏死性凋亡影响心肌缺血再灌注损伤的机制研究
- 批准号:82370288
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
应激颗粒自噬对低氧诱导猪卵泡颗粒细胞凋亡的影响及机制研究
- 批准号:32302741
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Determining the ultrastructural differences between dually and singly innervated dendritic spines and their changes following glutamate excitotoxicity using Cryo-Electron Tomography
使用冷冻电子断层扫描确定双重和单神经支配的树突棘之间的超微结构差异及其在谷氨酸兴奋性毒性后的变化
- 批准号:
10679214 - 财政年份:2023
- 资助金额:
$ 28.86万 - 项目类别:
Temporary plasma membrane disruptions in corneal epithelium and keratocytes.
角膜上皮和角膜细胞的暂时质膜破坏。
- 批准号:
10630403 - 财政年份:2023
- 资助金额:
$ 28.86万 - 项目类别:
Evaluation of anti-fibrotic and anti-inflammatory semi-synthetic oxysterol, Oxy210, as a therapeutic drug candidate for non-alcoholic steatohepatitis
抗纤维化和抗炎半合成氧甾醇 Oxy210 作为非酒精性脂肪性肝炎候选治疗药物的评价
- 批准号:
10697132 - 财政年份:2023
- 资助金额:
$ 28.86万 - 项目类别:
Evaluating the effects of hexavalent chromium on uterine vascular remodeling
评估六价铬对子宫血管重塑的影响
- 批准号:
10581242 - 财政年份:2023
- 资助金额:
$ 28.86万 - 项目类别: